Analytical Data
-
Gene name
MT2731
- Application
-
Alternative Names
MT2731; Antitoxin MT2731
-
Species
Mycobacterium tuberculosis
-
Source
Yeast
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P9WJ10
-
Expression Region
1-81aa
-
Molecular Weight
9.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MT2731 is a recombinant protein derived from the synthesis of a specific gene, often involved in various biological functions and applications in scientific research. The study of recombinant proteins like MT2731 is vital for understanding molecular mechanisms in disease pathology, protein interactions, and cellular processes. In the context of MT2731, research has focused on its structure-function relationship, as well as its potential therapeutic applications, such as in drug development or as a biomarker for certain diseases. Furthermore, advancements in genetic engineering techniques, such as CRISPR and recombinant DNA technology, have facilitated the efficient production of MT2731, allowing researchers to investigate its properties in vitro and in vivo. The insights gained from these studies contribute to a broader understanding of protein biology, enhancing the development of novel therapies and diagnostic tools. As the field of biotechnology continues to evolve, MT2731 serves as a model for exploring the intricacies of protein function and its implications in health and disease.
